Sercolab SRL
1.0 FTEThe score of Sercolab shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -55 % Total assets +3 % Headcount (avg FTE) -50 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sercolab's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −35,177 € | ||||
| Equity | 77,663 € | ||||
| Cash | 44,650 € | ||||
| EBITDA | −32,208 € | ||||
| Total assets | 389,069 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jul 2026
- Year ended 31 Dec 2024filed on 08 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Sercolab's financial analysis
- Solvency20.0%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sercolab
Sercolab's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0431.052.360
- VAT number
- BE0431052360
- Peppol
- Registered · 0208:0431052360 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Apr 1987
- Registered office
- 2170 Antwerp
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 09 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Sercolab (SRL) has been based in Antwerp since 1987, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 35,177 € and equity of 77,663 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 20.0%, below the median of its sector (46.0%).
Companies similar to Sercolab
Companies in the same business, of comparable size and area, outside its group.
- Dimed Medical Engineering Wholesale of electrical household appliances Antwerp · balance sheet €1.68m
- Laborimpex Wholesale of pharmaceutical and medical goods Forest · balance sheet 441,502 €
- Greiner BIO-ONE Wholesale of pharmaceutical and medical goods Vilvoorde · balance sheet €1.12m
- Tomcare Wholesale of other household goods Sint-Lievens-Houtem · balance sheet 410,966 €
- Melphar Wholesale of other food Scherpenheuvel-Zichem · balance sheet 583,824 €
- Themico Activities of agents involved in the wholesale of furniture, household goods, hardware and ironmongery Ghent · balance sheet 728,629 €
- Omega Pharma Trading Wholesale of other household goods Ghent · balance sheet €2.82m
- Nenko Belgie Wholesale of other household goods Pelt · balance sheet 390,263 €
Frequently asked questions about Sercolab
What is the revenue of Sercolab?
Sercolab files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sercolab?
In Belgium, the VAT number is the company number prefixed with BE: BE0431052360 for Sercolab, if the company is VAT-registered. Its company number (CBE) is 0431.052.360.
Where is the registered office of Sercolab?
According to the CBE register, the registered office of Sercolab is in 2170 Antwerp.
What is the equity of Sercolab?
At the close of the 2025 financial year, the equity of Sercolab amounts to 77,663 €, a solvency of 20.0% of total assets.
How many people work at Sercolab?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Sercolab?
The register lists 1 active mandates at Sercolab. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sercolab
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →